In consistence, a study investigating the expression of all HER-family members in bladder cancer found that while EGFR and HER2 expression rates alone do not correlate with survival, higher EGFR or HER2 expression combined with low HER3 and HER4 expression result in a worse prognosis (185). This evidence concerns the gene EGFR and urinary bladder cancer.